Form 4: Vaxcyte COO Sells Shares
Insider Transaction (Form 4)
Jim Wassil, CHIEF OPERATING OFFICER of Vaxcyte, Inc., sold 3,477 shares of common stock on August 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,273 Common Stock at $60.74 ($77,322) on August 31, 2026; holds 156,268 after (Direct).
- Option exercise/conversion: acquired 2,250 Common Stock at $5.35 ($12,038) on September 1, 2026; holds 158,518 after (Direct).
- Open-market sale: disposed of 1,537 Common Stock at $60.89 ($93,582) on September 1, 2026; holds 156,981 after (Direct).
- Open-market sale: disposed of 713 Common Stock at $61.48 ($43,836) on September 1, 2026; holds 156,268 after (Direct).
- Open-market sale: disposed of 924 Common Stock at $60.95 ($56,322) on September 1, 2026; holds 155,344 after (Direct).
- Open-market sale: disposed of 303 Common Stock at $61.42 ($18,611) on September 1, 2026; holds 155,041 after (Direct).
- Tax/exercise-price withholding: disposed of 1,432 Common Stock at $61.58 ($88,183) on September 2, 2026; holds 153,609 after (Direct).
- Option exercise/conversion: disposed of 2,250 Stock Option (right to buy) on September 1, 2026; holds 66,648 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $212,352 of stock on the open market.
Insider Transactions
Jim Wassil — Officer (CHIEF OPERATING OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Common Stock | 1,273 | $61 | $77.3K | 156,268 |
| 2026-09-01 | Option exercise/conversion | Common Stock | 2,250 | $5 | $12.0K | 158,518 |
| 2026-09-01 | Open-market sale | Common Stock | 1,537 | $61 | $93.6K | 156,981 |
| 2026-09-01 | Open-market sale | Common Stock | 713 | $61 | $43.8K | 156,268 |
| 2026-09-01 | Open-market sale | Common Stock | 924 | $61 | $56.3K | 155,344 |
| 2026-09-01 | Open-market sale | Common Stock | 303 | $61 | $18.6K | 155,041 |
| 2026-09-02 | Tax/exercise-price withholding | Common Stock | 1,432 | $62 | $88.2K | 153,609 |
| 2026-09-01 | Option exercise/conversion | Stock Option (right to buy) | 2,250 | — | — | 66,648 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (1,273 shares) |
| 2026-09-01 | Option exercise/conversion (2,250 shares) |
| 2026-09-01 | Open-market sale (1,537 shares) |
| 2026-09-01 | Open-market sale (713 shares) |
| 2026-09-01 | Open-market sale (924 shares) |
| 2026-09-01 | Open-market sale (303 shares) |
| 2026-09-02 | Tax/exercise-price withholding (1,432 shares) |
| 2026-09-01 | Option exercise/conversion (2,250 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., bearish, Jim Wassil
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.